Showing results (661-670 of 1,025) with videos related to

Sort By:
Pageof 103
Journal of Neurology|June 29, 2018
Assessment of Duodopa<sup>®</sup> effects on quality of life of patients with advanced Parkinson's disease and their caregiversRosella Ciurleo, Francesco Corallo, Lilla Bonanno, et al.
Vaccines|January 30, 2020
Evaluation of the Burden of HPV-Related Hospitalizations as a Useful Tool to Increase Awareness: 2007-2017 Data from the Sicilian Hospital Discharge RecordsVincenzo Restivo, Claudio Costantino, Livia Amato, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|January 26, 2016
Use of the new da Vinci Xi® during robotic rectal resection for cancer: a pilot matched-case comparison with the da Vinci Si®Luca Morelli, Simone Guadagni, Gregorio Di Franco, et al.
Journal of the Neurological Sciences|April 30, 1998
Juvenile Leigh syndrome with protracted course presenting as chronic sensory motor neuropathy, ataxia, deafness and retinitis pigmentosa: a clinicopathological reportA Malandrini, S Palmeri, G M Fabrizi, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 24, 2025
Evaluation of 3D ARFI imaging of prostate cancer: diagnostic reliability and concordance with MpMRISpencer R Moavenzadeh, Derek Y Chan, Eric S Adams, et al.
Annali Italiani Di Chirurgia|September 1, 1992
[Anatomo-clinical considerations on early gastric cancer]S Gorgone, A G Rizzo, G Navarra, et al.
Neuropharmacology|April 22, 2015
Object memory enhancement by combining sub-efficacious doses of specific phosphodiesterase inhibitorsE Bollen, S Akkerman, D Puzzo, et al.
European Journal of Neurology|July 22, 2008
Body mass index does not change before Parkinson's disease onsetP Ragonese, M D'Amelio, G Callari, et al.
Toxicology and Applied Pharmacology|July 15, 2009
Bromocriptine induces parapoptosis as the main type of cell death responsible for experimental pituitary tumor shrinkageClaudia Mariela Palmeri, Juan Pablo Petiti, Liliana del Valle Sosa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology GroupP Comella, F De Vita, L De Lucia, et al.
Pageof 103